Table 3.
Compound |
c [μm] |
Decrease of viability [%] after 48 h[a] |
||
---|---|---|---|---|
HepG2 |
HEK293 |
A549 |
||
5 a (thiol) |
100 |
15±9 |
53±0 |
18±12 |
26 (phosphonate) |
100 |
8±10 |
32±4 |
20±2 |
rifampicin |
100 |
33±13 |
29±13 |
9±13 |
doxorubicin |
1 |
57±14 |
47±9 |
53±13 |
epirubicin |
1 |
68±10 |
49±11 |
56±12 |
[a] Means of at least two independent measurements.